Numerous biomarkers are currently used in BC management, notably tissue marker expression of different receptors (estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)) that is daily used for patients’ staging [403,404]. The gene discussed is ERBB2; the disease is breast cancer.